Halozyme Therapeutics
HALO
#2478
Rank
C$8.17 B
Marketcap
$64.28
Share price
-15.40%
Change (1 day)
18.27%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of September 2024 : C$0.63 Billion

According to Halozyme Therapeutics's latest financial reports the company has C$0.63 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$0.11 B-51.76%
2022-12-31$C$0.23 B-8.21%
2021-12-31$C$0.25 B30.33%
2020-12-31$C$0.19 B60.7%
2019-12-31$C$0.11 B-64.65%
2018-12-31$C$0.33 B29.42%
2017-12-31$C$0.26 B-700.16%
2016-12-31$-C$43.65 Million-173.18%
2015-12-31$C$59.64 M24.3%
2014-12-31$C$47.98 M-325.52%
2013-12-31$-C$21.28 Million-143.8%
2012-12-31$C$48.58 M338.15%
2011-12-31$C$11.08 M-45.5%
2010-12-31$C$20.34 M180.07%
2009-12-31$C$7.26 M-61.16%
2008-12-31$C$18.7 M-67.55%
2007-12-31$C$57.62 M114.45%
2006-12-31$C$26.87 M26.78%
2005-12-31$C$21.19 M19.05%
2004-12-31$C$17.8 M3571.96%
2003-12-31$C$0.48 M-180.89%
2002-12-31$-C$0.6 Million-1747.73%
2001-12-31$C$0.03 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-C$0.32 Billion-149.87%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.16 B 3,063.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.85 B 1,602.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$130.32 B 20,345.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$110.17 B 17,185.42%๐Ÿ‡ซ๐Ÿ‡ท France
C$98.78 B 15,397.58%๐Ÿ‡บ๐Ÿ‡ธ USA